| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2025 | Feb 19, 2025 | Aardvark Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +1,250,000 | 46.86% | ✗ | $20M |
| Jan 29, 2024 | Apr 9, 2024 | CG Oncology, Inc. | 10% Owner | Buy | 96.3 | +400,000 | 8.77% | ✗ | $7.6M |
| Jan 29, 2024 | Jan 31, 2024 | CG Oncology, Inc. | 10% Owner | Buy | 100.0 | +400,000 | 100.00% | ✗ | $7.6M |